Megumi Funakoshi-Tago

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 6

Top Topics

Epidermal Growth Factor Receptor

Acute Myeloid Leukemia

Inflammatory Response

Top Venues

The FEBS journal

Molecular oncology

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Shingo Hokimoto, Megumi Funakoshi-Tago, Kenji Tago
Identification of DDX5 as an indispensable activator of the glucocorticoid receptor in adipocyte differentiation. The FEBS journal (2022)
Satoshi Ohta, Kenji Tago, Takahiro Kuchimaru, Megumi Funakoshi-Tago, Hisanaga Horie, Chihiro Aoki-Ohmura, Jitsuhiro Matsugi, Ken Yanagisawa
The role of MerTK in promoting cell migration is enhanced by the oncogenic Ras/IL-33 signaling axis. The FEBS journal (2021)
Megumi Funakoshi-Tago, Yusuke Nonaka, Kenji Tago, Mika Takeda, Yuma Ishihara, Ami Sakai, Mari Matsutaka, Kenji Kobata, Hiroomi Tamura
Pyrocatechol, a component of coffee, suppresses LPS-induced inflammatory responses by inhibiting NF-κB and activating Nrf2. Scientific reports 10 (1) (2020)
Yuki Uchihara, Kenji Tago, Hiroomi Tamura, Megumi Funakoshi-Tago
EBP2, a novel NPM-ALK-interacting protein in the nucleolus, contributes to the proliferation of ALCL cells by regulating tumor suppressor p53. Molecular oncology 15 (1) (2020)
Kenji Tago, Megumi Funakoshi-Tago, Satoshi Ohta, Hirotoshi Kawata, Hiroshi Saitoh, Hisanaga Horie, Chihiro Aoki-Ohmura, Junji Yamauchi, Akira Tanaka, Jitsuhiro Matsugi, Ken Yanagisawa
Oncogenic Ras mutant causes the hyperactivation of NF-κB via acceleration of its transcriptional activation. Molecular oncology 13 (11) (2019)
Yuki Uchihara, Fumihito Ueda, Kenji Tago, Yosuke Nakazawa, Tomoyuki Ohe, Tadahiko Mashino, Shigenobu Yokota, Tadashi Kasahara, Hiroomi Tamura, Megumi Funakoshi-Tago
Alpha-tocopherol attenuates the anti-tumor activity of crizotinib against cells transformed by NPM-ALK. PloS one 12 (8) (2017)